Navigation Links
NewLink Initiates Pivotal Phase 3 Clinical Trial of HyperAcute(R)-Pancreas Immunotherapy for Resected Pancreatic Cancer
Date:5/27/2010

characteristically aggressive with non-specific initial symptoms, making it difficult to diagnose early. Conventional therapies have little impact on prognosis and disease outcome.

Surgical resection of the tumor is currently the only chance for a cure. Without resection, overall median survival is four to six months with an estimated five-year survival rate of 0.4 percent to 5 percent. Resection increases median survival to 13 to 15 months with five-year survival of about 10 percent, which may be extended to 20 months and 24 to 30 percent, respectively, with adjuvant chemotherapy. Unfortunately, only 10 to 15 percent of patients are deemed candidates for resection given the stage of their disease by the time they are diagnosed.

About NewLink Genetics Corporation

NewLink Genetics Corporation is a biopharmaceutical company applying innovative technologies to create new therapeutic agents for patients with cancer and infectious diseases. Its products are designed to enhance the patient's immune system, enabling the body's immune cells to target pathogens and diseased tissues. For more information please visit us at www.newlinkgenetics.com.


'/>"/>
SOURCE NewLink Genetics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. NewLink Genetics Corporation Closes $7.5 Million Financing
2. NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
5. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
6. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
7. Nventa Initiates HspE7 Phase 1 Cervical Dysplasia Trial
8. Cytochroma initiates Phase I/II clinical trial of CTAP101 Capsules for vitamin D insufficiency in chronic kidney disease
9. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
10. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
11. Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 As ... MeMD, Inc proudly announces the release of their ... and Fitness ". , MeMD's goal was to ... landscape of Health 2.0, Health 3.0 and mHealth.The ... likely transform medical care and the fitness industry ...
(Date:6/18/2013)... Minneapolis, MN (PRWEB) June 18, 2013 ... the Saniclave 200 prevent the dangers of ... confusing features, like knobs, analog pressure gauges, hot surfaces ... older autoclave, or a new, modern autoclave, Revolutionary Science ... use fresh water. Older autoclave designs will recycle ...
(Date:6/18/2013)... On June 11, 2013 the Centers for Medicare ... memorandum concluding that FDG Position Emission Tomography (PET) is ... strategy, and the agency ended the requirement for ... was developed jointly by the ACR and WMIS as ... Evidence Development (CED) program to determine if FDG-PET scans ...
(Date:6/17/2013)... FRANCISCO , June 17, 2013  KaloBios Pharmaceuticals, ... appointment of Donald R. Joseph as Chief ... years of biopharmaceutical industry experience and has worked in ... global health non-profit organizations. (Logo: ... successful track record as a general counsel and senior ...
Breaking Biology Technology:MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4
... CLAREMONT, Calif., Oct. 25, 2011 Keck Graduate Institute (KGI) ... speaker at the upcoming Pichia 2012 conference from February 23 ... spent years conducting internationally-renowned research on the development and use ... system for the production of recombinant proteins. At ...
... JUNCTION, N.J., Oct. 25, 2011 Insmed Incorporated (Nasdaq CM: ... Tuesday, November 8 th , 2011, at 8:30 AM ET, ... 2011.  Insmed intends to issue its quarterly financial results press ... To participate in the live conference call, ...
... Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the ... on operations and disclosed the outcome of a strategic ... management and AMT,s Board of Directors that enables the ... development. The CHMP,s recent opinion, while not approving Glybera®, ...
Cached Biology Technology:KGI Professor Cregg to Be Featured Speaker at Pichia 2012 Conference 2Insmed to Host 2011 Third Quarter Earnings Conference Call 2Insmed to Host 2011 Third Quarter Earnings Conference Call 3Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 2Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 3Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 4
(Date:6/17/2013)... Biochemical and Biophysical Research Communications , Saint Louis ... previously unknown viruses. The technique offers the potential to ... identified a particular virus as the likely source of ... scientists use blood serum as a biological source to ... complete deciphering of the human genome, SLU researchers used ...
(Date:6/17/2013)... bacteria, and algae, is a common component of sugar-free ... the medical field it,s approved by the FDA ... used during surgery as a substance that opens the ... , Now Profs. Ehud Gazit and Daniel Segal of ... and the Sagol School of Neuroscience, along with their ...
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
Breaking Biology News(10 mins):Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3Artificial sweetener a potential treatment for Parkinson's disease 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... International Scientific Congress attended by more than 2,500 delegates ... The conclusions will be published as a full report ... the Danish Prime Minister Mr. Anders Fogh Rasmussen today. ... Conference in December 2009 and will hand over the ...
... have taken a first look at the broad genetic ... Although scientists have known for more than a century ... are likely to suffer from low reproductive success, the ... still the subject of debate. The new study, ...
... An international research team, involving Professor Rajeev Ahuja at ... to understand the mechanism behind the catalytic effects of ... a synergistic approach and the results, published this week ... Letters , will fasten efforts to develop new catalysts. ...
Cached Biology News:'Climate change: Global risks, challenges and decisions' 2'Climate change: Global risks, challenges and decisions' 3Researchers take first look at the genetic dynamics of inbreeding depression 2Researchers take first look at the genetic dynamics of inbreeding depression 3Revealing new applications for carbon nanomaterials in hydrogen storage 2
... the professional, student, or faculty researcher, the new ... your research and improve the quality of your ... the edge that researchers using LI-COR DNA analysis ... The 4300 System is a third generation instrument ...
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... testing at various temperatures, this chamber ... a clean heating unit to maintain ... 140F. Transparent panels allow full visibility, ... access to the work area. Includes ...
... Label IT siRNA Tracker Intracellular Localization ... a straight forward approach to directly ... design, in an efficient yet non-destructive ... Subcellular localization and functional inhibition of ...
Biology Products: